We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Regeneron Pharmaceuticals
REGN
$82B
| $389K | 0.01% |
742
-233
| -24% | -$130K |
2016 Q4
34 quarters
|
|
727
DELISTED
Kellanova
K
| $387K | 0.01% |
4,863
-657
| -12% | -$53.7K |
2016 Q4
34 quarters
|
|
728
Allegion
ALLE
$13.2B
| $387K | 0.01% |
2,682
-64
| -2% | -$8.75K |
2016 Q4
34 quarters
|
|
729
Artisan Partners
APAM
$2.33B
| $386K | 0.01% |
8,711
-32
| -0.4% | -$1.28K |
2021 Q3
15 quarters
|
|
730
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50.4B
| $385K | 0.01% |
7,856
-24,836
| -76% | -$1.21M |
2016 Q4
34 quarters
|
|
731
NRG Energy
NRG
$21.6B
| $385K | 0.01% |
2,395
+33
| +1% | +$4.35K |
2016 Q4
34 quarters
|
|
732
British American Tobacco
BTI
$125B
| $382K | 0.01% |
8,061
-327
| -4% | -$14.5K |
2016 Q4
34 quarters
|
|
733
Shift4
FOUR
$3.11B
| $380K | 0.01% |
3,835
+318
| +9% | +$27.7K |
2021 Q1
17 quarters
|
|
734
Sportradar
SRAD
$3.59B
| $377K | 0.01% |
13,425
+4,040
| +43% | +$95.9K |
2024 Q1
5 quarters
|
|
735
LyondellBasell Industries
LYB
$20.2B
| $377K | 0.01% |
6,509
+601
| +10% | +$35K |
2016 Q4
34 quarters
|
|
736
Vanguard Extended Market ETF
VXF
$30.1B
| $376K | 0.01% |
1,953
-80
| -4% | -$14.2K |
2017 Q1
33 quarters
|
|
737
Takeda Pharmaceutical
TAK
$62.1B
| $376K | 0.01% |
24,338
+4,485
| +23% | +$66.3K |
2019 Q1
25 quarters
|
|
738
Vanguard Global ex-US Real Estate ETF
VNQI
$3.25B
| $375K | 0.01% |
8,133
-32
| -0.4% | -$1.38K |
2016 Q4
34 quarters
|
|
739
Vanguard Long-Term Bond ETF
BLV
$5.45B
| $374K | 0.01% |
5,385
+4,747
| +744% | +$324K |
2023 Q3
7 quarters
|
|
740
Sysco
SYY
$40.4B
| $374K | 0.01% |
4,940
+371
| +8% | +$26.9K |
2016 Q4
34 quarters
|
|
741
Dimensional US Core Equity Market ETF
DFAU
$13B
| $374K | 0.01% |
8,831
| – | – |
2023 Q4
6 quarters
|
|
742
SK Telecom
SKM
$12.6B
| $373K | 0.01% |
15,955
+13,465
| +541% | +$290K |
2017 Q3
31 quarters
|
|
743
Wheaton Precious Metals
WPM
$60.5B
| $372K | 0.01% |
4,146
+76
| +2% | +$6.4K |
2016 Q4
34 quarters
|
|
744
Veralto
VLTO
$24.6B
| $372K | 0.01% |
3,684
+24
| +0.7% | +$2.31K |
2023 Q4
6 quarters
|
|
745
iShares Russell Top 200 Value ETF
IWX
$3.38B
| $370K | 0.01% |
4,398
| – | – |
2024 Q2
4 quarters
|
|
746
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11B
| $370K | 0.01% |
10,492
+1,420
| +16% | +$47.6K |
2024 Q4
2 quarters
|
|
747
Alerian MLP ETF
AMLP
$12.5B
| $369K | 0.01% |
7,558
+572
| +8% | +$27.7K |
2016 Q4
34 quarters
|
|
748
U.S. Small Cap Portfolio ETF Class Shares
DFAS
$15B
| $369K | 0.01% |
5,795
-836
| -13% | -$50.1K |
2022 Q1
13 quarters
|
|
749
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
| $369K | 0.01% |
4,850
+1,300
| +37% | +$94.6K |
2025 Q1
1 quarter
|
|
750
Elbit Systems
ESLT
$34.8B
| $364K | 0.01% |
809
-3
| -0.4% | -$1.22K |
2016 Q4
34 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.